Lung Cancer Screening Eligible Population from 2000 to 2050 in Argentina. A simulation study brief report

JTO Clinical and Research Reports · Published 2026-04-01 · DOI 10.1016/j.jtocrr.2026.101006

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.jtocrr.2026.101006

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Tarlatamab in Relapsed Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: A Case with Comparative DLL3 Expression Analysis · JTO Clinical and Research Reports · 2026 · Same journal
• Lung Cancer Screening Recommendations in the Elderly: International Society for Geriatric Oncology (SIOG) Consensus Statement · JTO Clinical and Research Reports · 2026 · Same journal
• Comparison of long-term survival between nivolumab plus ipilimumab and nivolumab plus ipilimumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study · JTO Clinical and Research Reports · 2026 · Same journal
• Concurrent Hypertrophic Osteoarthropathy and Immune Checkpoint Inhibitor–Induced Inflammatory Arthritis in a Patient With NSCLC: A Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Trastuzumab Deruxtecan Induces Complete Pathological Response in Oligometastatic HER2-Mutant NSCLC: Case Report · JTO Clinical and Research Reports · 2026 · Same journal
• Safety and Efficacy of Bronchoscopic Pulsed Electric Field Ablation for Lung Cancer and Metastases · JTO Clinical and Research Reports · 2026 · Same journal
• Multi-Institutional Integration of Circulating miRNAs and Protein Tumor Markers for Early Lung Cancer Detection · JTO Clinical and Research Reports · 2026 · Same journal
• Clinical and Genomic Characteristics of Patients With Advanced NSCLC Who Have Long-Term Response to First-Line Immunotherapy: A Real-World Study · JTO Clinical and Research Reports · 2026 · Same journal
• Pembrolizumab Plus Chemotherapy for Metastatic Squamous Non‒Small-Cell Lung Cancer: Long-Term Follow-Up of the KEYNOTE-407 China Study · JTO Clinical and Research Reports · 2026 · Same journal